Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 8c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of ($0.48), $0.08 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $67.7 million versus the consensus estimate of $59.57 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low